You are here
Drugmaker Mylan's woes get worse with president engulfed in vast probe
MYLAN NV's latest troubles couldn't come at a worse time.
Two years ago, Mylan was a swaggering drugmaker on the way up, buying up rivals as it grew and diversified.
Then it faced political scrutiny over price hikes for its EpiPen allergy shot and increasing
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org